With the right plan and support, you can absolutely move forwardwhether that means tweaking your medication, trying a new strategy, or going all-in on lifestyle changes
Since the FDA removed semaglutide from the shortage list in February 2025, the legal basis for 503B compounding has been restricted
The short answer is yes, but the experience of eating high-fat, high-sugar foods often changes significantly once you begin a glucagon-like peptide-1 (GLP-1) receptor agonist
Emerging Research on GLP-1 Drugs and Addiction Recent studies suggest that GLP-1 receptor agonists, medications like semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda), may influence alcohol use and addictive behaviors by acting on the brains reward pathways
People with severe gut disease should be tracked carefully, as the peptides effects on gut function could possibly exacerbate certain conditions